Page 121 - 《中国药房》2025年4期
P. 121
competent adolescent[J]. Int J Infect Dis,2023,134: recovered from cancer patients with phaeohyphomycosis
207-210. [J]. Diagn Microbiol Infect Dis,2010,66(2):200-203.
[ 4 ] SELF W H,WILLIAMS D J,ZHU Y W,et al. Respira‐ [14] OGAWA H,FUJIMURA M,AMAIKE S,et al. Eosino‐
tory viral detection in children and adults:comparing philic pneumonia caused by Alternaria alternata[J].
asymptomatic controls and patients with community- Allergy,1997,52(10):1005-1008.
acquired pneumonia[J]. J Infect Dis,2016,213(4): [15] CHOWDHARY A,AGARWAL K,RANDHAWA H S,et
584-591. al. A rare case of allergic bronchopulmonary mycosis
[ 5 ] BRUMINHENT J,WORAWICHAWONG S,TONGSOOK caused by Alternaria alternata[J]. Med Mycol,2012,50
C,et al. Epidemiology and outcomes of early-onset and (8):890-896.
late-onset adenovirus infections in kidney transplant [16] SHASHIKALA R P,SAIKUMAR A,RAMESH K,et al.
recipients[J]. Open Forum Infect Dis,2019,6(12): Alternaria alternata in a case of mass in the lung[J].
ofz489. Indian J Med Microbiol,2013,31(3):308-310.
[ 6 ] YING B L,TOLLEFSON A E,SPENCER J F,et al. Gan‐ [17] SEČNÍKOVÁ Z,JŮZLOVÁ K,VOJÁČKOVÁ N,et al.
ciclovir inhibits human adenovirus replication and patho‐ The rare case of Alternaria alternata cutaneous and pul‐
genicity in permissive immunosuppressed Syrian hamsters monary infection in a heart transplant recipient treated by
[J]. Antimicrob Agents Chemother,2014,58(12):7171- azole antifungals[J]. Dermatol Ther,2014,27(3):
7181. 140-143.
[ 7 ] 中国医药教育协会感染疾病专业委员会. 降钙素原指导 [18] GONZÁLEZ G M. In vitro activities of isavuconazole
抗菌药物临床合理应用专家共识[J]. 中华医学杂志, against opportunistic filamentous and dimorphic fungi[J].
2020,100(36):2813-2821. Med Mycol,2009,47(1):71-76.
Infectious Diseases Professional Committee of China [19] ALASTRUEY-IZQUIERDO A,CUESTA I,ROS L,et al.
Medicine Education Association. Expert consensus on the Antifungal susceptibility profile of clinical Alternaria spp.
rational clinical use of antibiotics guided by procalcitonin identified by molecular methods[J]. J Antimicrob Che‐
[J]. Natl Med J China,2020,100(36):2813-2821. mother,2011,66(11):2585-2587.
[ 8 ] SIVAGNANAM S,PODCZERVINSKI S,BUTLER-WU [20] PASTOR F J,GUARRO J. Alternaria infections:labora‐
S M,et al. Legionnaires’ disease in transplant recipients: tory diagnosis and relevant clinical features[J]. Clin Mi‐
a 15-year retrospective study in a tertiary referral center crobiol Infect,2008,14(8):734-746.
[J]. Transpl Infect Dis,2017,19(5):e12745. [21] GERDSEN R,UERLICH M,DE HOOG G S,et al. Sporo‐
[ 9 ] HAEUPTLE J,ZABORSKY R,FIUMEFREDDO R,et trichoid phaeohyphomycosis due to Alternaria infectoria
al. Prognostic value of procalcitonin in Legionella pneu‐ [J]. Br J Dermatol,2001,145(3):484-486.
monia[J]. Eur J Clin Microbiol Infect Dis,2009,28(1): [22] 石炳毅,巨春蓉. 器官移植受者侵袭性真菌病临床诊疗
55-60. 技术规范:2019版[J]. 器官移植,2019,10(3):227-236.
[10] DEMERS M. Alternaria alternata as endophyte and SHI B Y,JU C R. Technical specification for clinical diag‐
pathogen[J]. Microbiology(Reading),2022,168(3): nosis and treatment for invasive fungal disease in organ
001153. transplant recipients:2019 edition[J]. Organ Transplant,
[11] MAISONS V,DESOUBEAUX G,COUSTILLÈRES F, 2019,10(3):227-236.
et al. Intricate isavuconazole therapy of a subcutaneous [23] 陈恳,张相林,克晓燕,等. 《伏立康唑个体化用药指南》
nodule caused by Alternaria infectoria in a heart trans‐ 解读[J]. 临床药物治疗杂志,2019,17(3):47-52,78.
plant recipient[J]. J Mycol Med,2022,32(2):101235. CHEN K,ZHANG X L,KE X Y,et al. Executive sum‐
[12] IOSSIFOVA Y,REPONEN T,SUCHAREW H,et al. Use mary of The Practice Guideline for Individualized Medica‐
of(1-3)-beta-d-glucan concentrations in dust as a surro‐ tion of Voriconazole[J]. Clin Med J,2019,17(3):47-
gate method for estimating specific fungal exposures[J]. 52,78.
Indoor Air,2008,18(3):225-232. (收稿日期:2024-08-02 修回日期:2025-01-19)
[13] BEN-AMI R,ROCCO LASALA P,LEWIS R E,et al. (编辑:邹丽娟)
Lack of galactomannan reactivity in dematiaceous molds
中国药房 2025年第36卷第4期 China Pharmacy 2025 Vol. 36 No. 4 · 495 ·